Jay Venkatesan
Director · Elicio Therapeutics, Inc.
IndividualBuying only
- 2024
- Sep 2, 2026
- 6
Other insiders active in the same sector
No other insider has filed at Jay Venkatesan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jay Venkatesan?
Jay Venkatesan is a corporate insider, tracked as Director of Elicio Therapeutics, Inc. (ELTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jay Venkatesan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jay Venkatesan been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1K) and 0 open-market sales across all tracked filings.
